Question 1

Which countries lead Hepatology research?

Accepted Answer

On research quality in 2022-now, the United States, China and France rank highest in Hepatology. By volume, China and the United States publish the most (11k and 9.1k works in 2022-now).

Question 2

Which institutions lead Hepatology research?

Accepted Answer

Harvard University (United States) ranks first in Hepatology on research quality in 2022-now, followed by Stanford University and National Institutes of Health.

Question 3

Who are the leading researchers in Hepatology?

Accepted Answer

Counting only their work in Hepatology, Rohit Seth Loomba, Arun Jayant Sanyal and Vincent Wai‐Sun Wong have the most papers in the world top 10% for their subfield and year beyond the 10% expected.

Question 4

Where is Hepatology research done?

Accepted Answer

The largest centres of Hepatology research in 2022-now are Beijing (China), Guangzhou (China), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Ōgaki, Clichy and Doylestown.

Question 5

Where is the best place to study Hepatology?

Accepted Answer

Among universities, judged by research, Harvard University, Stanford University and University of California San Diego score highest, combining standing in the field's ranking, citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Hepatology research growing?

Accepted Answer

Output in 2022-2025 was 7% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Liver Diseases and Immunity, Liver Disease and Transplantation and Hepatocellular Carcinoma Treatment and Prognosis.

Question 7

What are the most cited papers in Hepatology?

Accepted Answer

The most cited paper in Hepatology is "Sorafenib in Advanced Hepatocellular Carcinoma" (Josep Maria Llovet et al., 2008), with 13,116 citations. Next come "Design and validation of a histological scoring system for nonalcoholic fatty liver disease†" (10,904) and "Management of Hepatocellular Carcinoma: An Update Δσ" (8,176).